Ads
related to: cetuximab approved indications for colonoscopy preparation- Patient Self-Care Kit
Skin & Nail Care Info. Learn How to
Order The Patient Self Care Kit.
- ERBITUX® (cetuximab)
HCPs View Prescribing, Dosing, &
Important Safety Information Here.
- Financial Assistance Info
See If Your Patients Are Eligible
For Our Reimbursement Program.
- Dose Modification Info
View Dosing Info Related to Side
Effects Of ERBITUX® (cetuximab).
- Patient Self-Care Kit
Search results
Results From The WOW.Com Content Network
Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer. [2] Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion .
Another common indication for colonoscopy is the investigation of iron deficiency with or without anaemia. The examination of the colon, to rule out a lesion contributing to blood loss, along with an upper gastrointestinal endoscopy (gastroscopy) to rule out oesophageal, stomach, and proximal duodenal sources of blood loss.
However, the prep for a colonoscopy is another story. You may need to drink a lot of fluids, spend quite a bit of time in the bathroom and temporarily change your diet.
Panitumumab was approved by the European Medicines Agency (EMEA) in 2007, and by Health Canada in 2008, for "the treatment of refractory EGFR-expressing metastatic colorectal cancer in patients with non-mutated (wild-type) KRAS". Panitumumab was the first monoclonal antibody to demonstrate the use of KRAS as a predictive biomarker.
The approval under the agency's accelerated process was based on an early- to mid-stage study, in which 94 previously treated patients were administered the oral drug Krazati, in combination with ...
A colonoscopy is typically performed under sedation. During that time, a gastroenterologist will insert a colonoscope, which is a flexible tube with a camera at the end, into the rectum, and will ...
The signs and symptoms of colorectal cancer depend on the location of the tumor in the bowel, and whether it has spread elsewhere in the body ().The classic warning signs include: worsening constipation, blood in the stool, decrease in stool caliber (thickness), loss of appetite, loss of weight, and nausea or vomiting in someone over 50 years old. [15]
Nimotuzumab (h-R3, [2] BIOMAb EGFR, Biocon, India; [3] TheraCIM, CIMYM Biosciences, Canada; Theraloc, Oncoscience, Europe, CIMAher, Center of Molecular Immunology, Havana, Cuba) is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck, and was ...
Ad
related to: cetuximab approved indications for colonoscopy preparation